CAAR applied the General Rules of Interpretation (GIR) for tariff classification, emphasizing the role of Section and Chapter ...

Delhi analyzed the classification of the “Rear Camera Integrated Module Subassembly,” a critical mobile phone component ...

This study provides a valuable new resource to investigate the molecular basis of the particular features characterizing the pipefish embryo. The authors found both unique and shared gene expression ...

This is an important study providing convincing evidence that increased blood pressure variability impairs myogenic tone and diminishes baroreceptor reflex. The study also provides evidence that blood ...

There is no known safe level of exposure to some of these pollutants, meaning that even low levels ... firefighters wear self-contained breathing apparatus (Scott air packs) because the air ...

2023), electrospinning technology has attracted considerable attention in neural tissue engineering and in vitro modeling, thanks to its ability to simply fabricate fibrous substrates resembling fiber ...

Mean (SD) heart rate was 76 (10 ... 20 In addition, reversible degradation of the cellular contractile apparatus in long standing dysfunctional myocardium may also contribute to the lack of ...

The Golgi apparatus is a vital organelle in cells, primarily responsible for processing and packaging proteins and lipids. It plays a crucial role in various cellular functions, including protein ...

Protein trafficking is a vital process in cellular biology, ensuring that proteins are correctly transported to their destinations within the cell. The Golgi apparatus plays a central role in this ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Intra-Cellular Therapies (ITCI) shares soared 14.9% in the last trading session to close at $94.87. The move was backed by solid volume with far more shares changing hands than in a normal session.

J&J has offered to buy each share of Intra-Cellular for $132, representing a 39% premium to the stock's closing price on Friday. Shares of Intra-Cellular rose 34% to $128 in afternoon trading ...